STAT3 Activation Promotes Oncolytic HSV1 Replication in Glioma Cells

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Okemoto, Kazuo ^a   Wagner, Benjamin ^a   Meisen, Hans ^a   Haseley, Amy ^a   Kaur, Balveen ^a   Chiocca, Ennio Antonio ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; ONCOLYTIC HERPES VIRUS; STAT3 PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; CYTOTOXICITY; GLIOMA CELL; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; NONHUMAN; ONCOLYTIC VIROTHERAPY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

ANTICONVULSANTS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL PROLIFERATION; COMBINED MODALITY THERAPY; GLIOMA; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; INTERFERON TYPE I; LUCIFERASES; ONCOLYTIC VIROTHERAPY; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; TUMOR CELLS, CULTURED; VALPROIC ACID; VIRUS REPLICATION;

EID: 84880971282     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071932     Document Type: Article

References (20)

1. Wollmann G, Ozduman K, van den Pol AN, (2012) Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates. Cancer J 18: 69-81. doi:10.1097/PPO.0b013e31824671c9.
2. Pesonen S, Kangasniemi L, Hemminki A, (2011) Oncolytic adenoviruses for the treatment of human cancer: focus on translational and clinical data. Mol Pharm 8: 12-28. doi:10.1021/mp100219n.
3. Hernandez-Alcoceba R, (2011) Recent advances in oncolytic virus design. Clin Transl Oncol 13: 229-239. doi:10.1007/s12094-011-0647-4. PubMed: 21493183.
4. Dempsey MF, Wyper D, Owens J, Pimlott S, Papanastassiou V, et al. (2006) Assessment of 123I-FIAU imaging of herpes simplex viral gene expression in the treatment of glioma. Nucl Med Commun 27: 611-617. doi:10.1097/00006231-200608000-00003. PubMed: 16829761.
5. Freeman AI, Zakay-Rones Z, Gomori JM, Linetsky E, Rasooly L, et al. (2006) Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme. Mol Ther 13: 221-228. doi:10.1016/j.ymthe.2005.08.016.
6. Kambara H, Okano H, Chiocca EA, Saeki Y, (2005) An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor. Cancer Res 65: 2832-2839. doi:10.1158/0008-5472.CAN-04-3227. PubMed: 15805284.
7. Agarwalla PK, Aghi MK, (2012) Oncolytic herpes simplex virus engineering and preparation. Methods Mol Biol 797: 1-19. doi:10.1007/978-1-61779-340-0_1. PubMed: 21948465.
8. Ahmed AU, Ulasov IV, Mercer RW, Lesniak MS, (2012) Maintaining and loading neural stem cells for delivery of oncolytic adenovirus to brain tumors. Methods Mol Biol 797: 97-109. doi:10.1007/978-1-61779-340-0_8.
9. Liu Y, Li C, Lin J, (2010) STAT3 as a Therapeutic Target for Glioblastoma. Anti Cancer Agents Med Chem 10: 512-519. doi:10.2174/187152010793498636.
10. Cooper LA, Gutman DA, Chisolm C, Appin C, Kong J, et al. (2012) The Tumor Microenvironment Strongly Impacts Master Transcriptional Regulators and Gene Expression Class of Glioblastoma. Am J Pathol, 180: 2108-19. PubMed: 22440258.
11. Otsuki A, Patel A, Kasai K, Suzuki M, Kurozumi K, et al. (2008) Histone deacetylase inhibitors augment antitumor efficacy of herpes-based oncolytic viruses. Mol Ther 16: 1546-1555. doi:10.1038/mt.2008.155. PubMed: 18648350.
12. Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, et al. (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463: 318-325. doi:10.1038/nature08712. PubMed: 20032975.
13. Wang WB, Levy DE, Lee CK, (2011). STAT3 negatively regulates type I IFN-mediated antiviral response. J Immunol 187: 2578-2585.
14. Kohsaka S, Wang L, Yachi K, Mahabir R, Narita T, et al. (2012). STAT3 inhibition overcomes temozolomide resistance in glioblastoma by downregulating MGMT expression. Mol Cancer Ther 11: 1289-1299.
15. Lin L, Hutzen B, Li PK, Ball S, Zuo M, et al. (2010) A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells. Neoplasia 12: 39-50.
16. Ball S, Li C, Li PK, Lin J, (2011) The small molecule, LLL12, inhibits. STAT3 phosphorylation and induces apoptosis in medulloblastoma and glioblastoma cells. PLOS ONE 6: e18820.
17. Hussain SF, Kong LY, Jordan J, Conrad C, Madden T, et al. (2007) A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients. Cancer Res 67: 9630-9636. doi:10.1158/0008-5472.CAN-07-1243. PubMed: 17942891.
18. Wei J, Wu A, Kong LY, Wang Y, Fuller G, et al. (2011) Hypoxia potentiates glioma-mediated immunosuppression. PLOS ONE 6: e16195. doi:10.1371/journal.pone.0016195. PubMed: 21283755.
19. Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, et al. (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463: 318-325. doi:10.1038/nature08712. PubMed: 20032975.
20. Alvarez-Breckenridge CA, Yu J, Price R, Wei M, Wang Y, et al. (2012) The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon. J Virol 86: 4566-4577. doi:10.1128/JVI.05545-11.